\
&
Contact us
This was 7 months ago
LocationRotterdam Science Tower in the Netherlands
ProgrammesYoung professionals and aspiring entrepreneurs are invited to participate in the 1st Benelux Space Startup Competition (SSC), taking place on May 1–2, 2025, at the Rotterdam Science Tower in the Netherlands.
Organized by the Space Generation Advisory Council (SGAC), this two-day event offers participants the chance to develop and pitch space-related business ideas, receive mentorship from industry experts, and present their concepts to a panel of investors and professionals.
SGAC is a non-governmental organization that supports the United Nations Programme on Space Applications and represents university students and young space professionals to the United Nations, national governments, space agencies, industry, and academia. With over 29,000 members in 170+ countries, SGAC empowers the next generation of space leaders through events, projects, and capacity-building initiatives.
Event links:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health AI Continent Deployment: Best use of technologies
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.